Literature DB >> 17336609

Proximal signaling events in Fc epsilon RI-mediated mast cell activation.

Taku Kambayashi1, Gary A Koretzky.   

Abstract

Mast cells are central mediators of allergic diseases. Their involvement in allergic reactions is largely dependent on activation through the specific receptor for IgE (Fc epsilon RI). Cross-linking of Fc epsilon RI on mast cells initiates a cascade of signaling events that eventually results in degranulation, cytokine/chemokine production, and leukotriene release, contributing to allergic symptomology. Because of the importance of IgE in allergy, much focus has been placed on deciphering the signaling events that take place downstream of Fc epsilon RI. Studies have identified spleen tyrosine kinase as a key proximal regulator of Fc epsilon RI-mediated signaling. In this review, we discuss the multiple pathways that diverge from spleen tyrosine kinase with emphasis on the role of adapter molecules to orchestrate these signaling events. Understanding the molecular mechanisms underlying mast cell activation ideally will provide insights into the development of novel therapeutics to control allergic disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336609     DOI: 10.1016/j.jaci.2007.01.017

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  36 in total

Review 1.  Deciphering the structure and function of FcεRI/mast cell axis in the regulation of allergy and anaphylaxis: a functional genomics paradigm.

Authors:  Jayapal Manikandan; Narasimhan Kothandaraman; Manoor Prakash Hande; Peter Natesan Pushparaj
Journal:  Cell Mol Life Sci       Date:  2011-12-07       Impact factor: 9.261

2.  Shaping the response: the role of FcεRI and Syk expression levels in mast cell signaling.

Authors:  Ambarish Nag; James R Faeder; Byron Goldstein
Journal:  IET Syst Biol       Date:  2010-11       Impact factor: 1.615

Review 3.  G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.

Authors:  Hye Sun Kuehn; Alasdair M Gilfillan
Journal:  Immunol Lett       Date:  2007-09-18       Impact factor: 3.685

4.  Fyn kinase regulates type II PtdIns 4-kinases in RBL 2H3 cells.

Authors:  Naveen Bojjireddy; Ranjeet Kumar Sinha; Gosukonda Subrahmanyam
Journal:  Mol Cell Biochem       Date:  2013-10-31       Impact factor: 3.396

5.  Characterization of ERK activation in human mast cells stimulated by contact with T cells.

Authors:  Adam Mor; Irit Shefler; Pazit Salamon; Yoel Kloog; Yoseph A Mekori
Journal:  Inflammation       Date:  2010-04       Impact factor: 4.092

6.  Notch ligand Delta-like1 enhances degranulation and cytokine production through a novel Notch/Dok-1/MAPKs pathway in vitro.

Authors:  Songsong Jiang; Yifan Da; Shiwen Han; Yahong He; Huilian Che
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

7.  Sinomenine potentiates P815 cell degranulation via upregulation of Ca2+ mobilization through the Lyn/PLCγ/IP3R pathway.

Authors:  Nan Wang; Rui Liu; Yanping Liu; Ruirui Zhang; Langchong He
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-29       Impact factor: 3.219

Review 8.  The role of diacylglycerol kinases in allergic airway disease.

Authors:  Taku Kambayashi; Deepak A Deshpande
Journal:  Curr Opin Pharmacol       Date:  2020-08-21       Impact factor: 5.547

9.  Negative control of mast cell degranulation and the anaphylactic response by the phosphatase lipin1.

Authors:  Jinwook Shin; Ping Zhang; Shang Wang; Jinhong Wu; Ziqiang Guan; Xiao-Ping Zhong
Journal:  Eur J Immunol       Date:  2012-11-26       Impact factor: 5.532

10.  Fluvastatin Suppresses Mast Cell and Basophil IgE Responses: Genotype-Dependent Effects.

Authors:  Elizabeth Motunrayo Kolawole; Jamie Josephine Avila McLeod; Victor Ndaw; Daniel Abebayehu; Brian O Barnstein; Travis Faber; Andrew J Spence; Marcela Taruselli; Anuya Paranjape; Tamara T Haque; Amina A Qayum; Qasim A Kazmi; Dayanjan S Wijesinghe; Jamie L Sturgill; Charles E Chalfant; David B Straus; Carole A Oskeritzian; John J Ryan
Journal:  J Immunol       Date:  2016-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.